NCOUNTER SPRINT Trademark

Trademark Overview


On Monday, August 4, 2014, a trademark application was filed for NCOUNTER SPRINT with the United States Patent and Trademark Office. The USPTO has given the NCOUNTER SPRINT trademark a serial number of 86357017. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, June 29, 2022. This trademark is owned by NanoString Technologies, Inc.. The NCOUNTER SPRINT trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Products & Electrical & Scientific Products categories with the following description:

computer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts th...

diagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising reagents for medical use; medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic rea...

diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, o...
ncounter sprint

General Information


Serial Number86357017
Word MarkNCOUNTER SPRINT
Filing DateMonday, August 4, 2014
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, June 29, 2022
Registration Number5124745
Registration DateTuesday, January 17, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 22, 2015

Trademark Statements


Goods and Servicescomputer-based apparatus for detection and analysis of gene expression for scientific use; computer-based apparatus for scientific research, namely, for collecting, processing, and taking images of data in connection with scientific or medical research, the use of diagnostic preparations and reagents for scientific or research use, RNA transcription and microRNA expression profiling, proteomics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, analysis of functional pathway gene sets, and monitoring of biofuel production, and prognostic, predictive, clinical, oncology, and hematology diagnostics; scientific research equipment for imaging single molecule reporters; scanning microscopes; fluorescent microscopes; laboratory equipment, namely, fluidics stations, hybridisation ovens, cartridges carriers and replacement parts therefor; scientific research instruments to process and analyze the single molecule reporters to manage and obtain information from the single molecule reporters; computer software to acquire, analyze and manage the biologic data generated; computer software for controlling fluidics station and scanner functions, for capturing fluorescent signals, and for extracting and analyzing data; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices; kits for scientific research use, namely, for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples, detecting the presence of analytes in samples and identifying sample types; diagnostic test kits for scientific use comprising microscope slides and microfluidic devices, reports, test results, research material, worksheets and other non-printed documents and publications, all being downloadable
Goods and Servicesdiagnostic reagents for medical use in the field of cancer; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use; diagnostic test kits for medical use comprising reagents, slides, solid matrix materials, microfluidic devices sold as a unit with instructional manuals therefor; medical diagnostic test kits for detecting pathogens, comprising reagents for medical use; medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type, sold as a unit with instructional manuals; replacement parts for medical diagnostic kits for use in detecting the presence of analytes in samples and identifying sample type, comprising equipment for screening samples detecting the presence of analytes in samples and identifying sample type; medical diagnostic reagents for RNA transcription and microRNA expression profiling, proteomics, small molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care, namely, medical diagnostic reagents and diagnostic reagents for clinical or medical laboratory use, diagnostic reagents for medical in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; tests designed to isolate and extract cells for genetic analysis comprised of reagents for medical diagnostic use; medical diagnostic reagents and assays for testing of body fluids; kits consisting primarily of medical diagnostic reagents and assays for testing of body fluids; reagents in the form of cell markers and molecule markers for medical purposes
Pseudo MarkENCOUNTER SPRINT
Goods and Servicesdiagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer; diagnostic test kits for scientific use comprising reagents, slides, solid matrix materials, microfluidic devices and support documentation therefor; diagnostic test kits comprising reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; diagnostic reagents for clinical or medical laboratory use, namely, reagents for proteomics, RNA transcription and microRNA expression profiling, small-molecule analysis, single nucleotide polymorphisms analysis, DNA sequencing, detection of polymorphisms in human fluids, detection of copy number variations, and clinical, oncology, and hematology diagnostics; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in the health care and other life science sectors, namely, reagents for scientific or medical research use, diagnostic preparations and reagents for scientific or research uses, namely, RNA transcription profiling, proteomics, clinical diagnostics, environmental monitoring, biosurveillance, agricultural inspection, forensic testing of samples containing microorganisms or human fluids, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing; test kits, consisting of chemical preparations for scientific purposes, in particular for the detection, diagnosis, progress monitoring and progress prediction of diseases, including inflammations, infections, disorders of the central nervous systems, cardiovascular, neurological, endocrine, autoimmune and genetic disorders and cancers; assays, reagents, enzymes, polymerases, buffers and nucleotides, and kits comprised thereof, all for scientific or research use; multiparameter quantitative detection and analysis products and technology for research and diagnostics for a variety of uses in life science sectors, namely, diagnostic reagents for scientific in vitro use in biochemistry, clinical chemistry and microbiology, RNA and microRNA expression transcription profiling, proteomics, clinical diagnostics, environmental monitoring, agricultural inspection, small-molecule analysis, single nucleotide polymorphisms analysis, and DNA sequencing

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateWednesday, August 13, 2014
Primary Code001
First Use Anywhere DateMonday, August 31, 2015
First Use In Commerce DateMonday, August 31, 2015

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 13, 2014
Primary Code005
First Use Anywhere DateMonday, August 31, 2015
First Use In Commerce DateMonday, August 31, 2015

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateWednesday, August 13, 2014
Primary Code009
First Use Anywhere DateSunday, May 31, 2015
First Use In Commerce DateSunday, May 31, 2015

Trademark Owner History


Party NameNanoString Technologies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Party NameNanoString Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Party NameNanoString Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98109

Trademark Events


Event DateEvent Description
Wednesday, June 29, 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, June 29, 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, June 29, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, January 25, 2022TEAS SECTION 8 & 15 RECEIVED
Monday, January 17, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, March 18, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, January 17, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, December 13, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, December 12, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, November 18, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 17, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, November 7, 2016USE AMENDMENT FILED
Thursday, November 17, 2016SOU EXTENSION 2 GRANTED
Monday, November 7, 2016SOU EXTENSION 2 FILED
Monday, November 7, 2016TEAS EXTENSION RECEIVED
Monday, November 7, 2016TEAS STATEMENT OF USE RECEIVED
Friday, June 10, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 9, 2016SOU EXTENSION 1 GRANTED
Friday, May 13, 2016SOU EXTENSION 1 FILED
Thursday, June 9, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, May 13, 2016TEAS EXTENSION RECEIVED
Tuesday, November 17, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 22, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 22, 2015PUBLISHED FOR OPPOSITION
Wednesday, September 2, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 19, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, August 12, 2015ASSIGNED TO LIE
Wednesday, July 29, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Sunday, July 12, 2015NOTICE OF REVIVAL - E-MAILED
Saturday, July 11, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 10, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 10, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 10, 2015PETITION TO REVIVE-GRANTED
Friday, July 10, 2015TEAS PETITION TO REVIVE RECEIVED
Monday, June 22, 2015ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Monday, June 22, 2015ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Monday, November 24, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, November 24, 2014NON-FINAL ACTION E-MAILED
Monday, November 24, 2014NON-FINAL ACTION WRITTEN
Monday, November 17, 2014ASSIGNED TO EXAMINER
Thursday, August 14, 2014NOTICE OF PSEUDO MARK E-MAILED
Wednesday, August 13, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, August 7, 2014NEW APPLICATION ENTERED IN TRAM